Chescapmanager’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
Chescapmanager's XLRN Position: Q4 2021 in Review
Chescapmanager sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 20,000 shares — an estimated $3.44M sold.
Chescapmanager first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $3.44M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.
- Chescapmanager reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
- Chescapmanager sold 20,000 Acceleron Pharma shares in Q4 2021, an estimated $3.44M.
- Chescapmanager first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
- Chescapmanager's Acceleron Pharma position peaked at $3.44M in Q3 2021.
- 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.
Based on Chescapmanager's 13F filing for Q4 2021, filed 11 Feb 2022.